Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Effect of Manual Medicine or Cognitive Behavioral Therapy With Chronic Uncontrolled Diabetes Within a Shared Primary Care Visit (A Randomized Clinical Trial)
Effects of manual medicine or cognitive behavioral therapy with chronic uncontrolled diabetes within a shared primary care visit. An evaluation of the effectiveness of manual therapy vs cognitive behavioral therapy (CBT) vs traditional primary care visit care is in need.
Integrating cognitive behavioral health nutritional therapy (hereafter CBT) and primary care
services plays an important role in healthcare outcomes and the prevalence of chronic
disorders treated in primary care. The Center of Disease Control has published some
disturbing numbers: 9.3% of the U.S. population is affected by diabetes. Ninety-five percent
of these individuals will receive treatment from their primary care provider, less than 5%
will consult with a dietitian or behavioral health provider. Diabetes is projected to triple
in the US despite numerous treatment options and greatly increased medical resources devoted
to this problem. There is need for treatments that demonstrate an effectiveness that is low
risk and wide spread.
A person's state of mind can play an important role in physical and psychosocial health
conditions such as diabetes. Depression and diabetes share a bidirectional association. A
recent meta-analysis reported that depressed individuals have a 60% increased risk of
developing diabetes. An association was found between the risks of developing diabetes and
non-severe depression, persistent depression, and untreated depression. Cognitive behavioral
therapy, among others, has demonstrated effectiveness for a variety of chronic conditions.
By implementing a shared visit with primary care we encourage the advancement of this new
approach. A focus on stress reduction by using mindfulness to encourage patients to think of
their body as a whole and heal through not only the use of CBT, but with nutrition and
manual therapy. Demonstrating the beneficial effects CBT has on uncontrolled diabetes will
offer another psychosocial treatment option for the large number of suffering US residents.
CBT and other mindfulness-based interventions have been recognized as helpful for a range of
conditions including chronic pain. However, only 1 large randomized clinical trial (RCT) has
evaluated CBT for chronic low back pain, and that trial was limited to older adults.
This clinical trial also includes chiropractic manipulative treatment (CMT) with
uncontrolled diabetes patients. This study is unique due to the lack of any pre-existing
trials of this nature. CMT has demonstrated improvement in physical function. A compromise
of the peripheral nervous system is a common long-term complication of diabetes. In severe
cases, this can lead to limb amputations and sudden cardiac death secondary to autonomic
polyneuropathy. Proper recognition of the musculoskeletal manifestations of patients with
diabetes will aid the treating chiropractor and alert them to the possible neurological
consequences of diabetes.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |